Sridhara Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 09-12-2024
- Paid Up Capital ₹ 1.69 Cr
as on 09-12-2024
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.03 Cr
as on 09-12-2024
- Revenue -38.39%
(FY 2022)
- Profit -28.80%
(FY 2022)
- Ebitda 54.46%
(FY 2022)
- Net Worth 16.09%
(FY 2022)
- Total Assets -8.24%
(FY 2022)
About Sridhara Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.69 Cr.
The company currently has active open charges totaling ₹8.03 Cr.
Venkateswara Dagupati, Srinivas Polavarapu, Ranga Tamma, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232TG2011PTC078321
- Company No.
078321
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Dec 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sridhara Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivas Polavarapu  | Managing Director | 30-Dec-2011 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkateswara Dagupati | Director | 04-Mar-2015 | Current |
| Ranga Tamma | Director | 30-Dec-2011 | Current |
| Narasimha Kattunga | Director | 04-Mar-2015 | Current |
| Hitesh Jain | Director | 04-Mar-2015 | Current |
Financial Performance of Sridhara Laboratories.
Sridhara Laboratories Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 38.39% decrease. The company also saw a substantial fall in profitability, with a 28.8% decrease in profit. The company's net worth Soared by an impressive increase of 16.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sridhara Laboratories?
In 2021, Sridhara Laboratories had a promoter holding of 29.53% and a public holding of 70.47%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
D-Valve Engineers India Private LimitedActive 7 years 9 monthsVenkateswara Dagupati is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 23 Dec 2021 | ₹5.30 M | Open |
Axis Bank Limited Creation Date: 12 Feb 2020 | ₹4.50 Cr | Open |
Others Creation Date: 06 Feb 2016 | ₹1.25 Cr | Open |
How Many Employees Work at Sridhara Laboratories?
Sridhara Laboratories has a workforce of 14 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sridhara Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sridhara Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
